These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 13558346)

  • 1. [Serum aldolase activity with special reference to multiple sclerosis, schizophrenia & alcoholism].
    JUVETH L
    Z Klin Med; 1957; 154(6):569-79. PubMed ID: 13558346
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activation of acid proteinase from rat brain in presence of blood serum from patients with multiple sclerosis and schizophrenia in in vitro experiments].
    Vilkov GA; Vovchenko IB; Mendzheritskiĭ AM; Trapezontseva RA
    Vopr Med Khim; 1983; 29(1):58-61. PubMed ID: 6340341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the degradation of cephalin by serum enzymes of normal and diseased persons with special reference to multiple sclerosis].
    SCHMALE H
    Confin Neurol; 1960; 20():424-51. PubMed ID: 13747868
    [No Abstract]   [Full Text] [Related]  

  • 4. [The methylating activity of the blood in schizophrenia].
    Reznikova SK; Stoliarov GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(1):92-6. PubMed ID: 4747515
    [No Abstract]   [Full Text] [Related]  

  • 5. [Latent redox potential of blood. With special reference to its behavior in multiple sclerosis].
    Holm V
    Ugeskr Laeger; 1966 Sep; 128(39):1158-62. PubMed ID: 5918438
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood groups in schizophrenia, alcoholism, and mental deficiency.
    NORDMO SH
    Am J Psychiatry; 1959 Nov; 116():460-1. PubMed ID: 14427588
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum toxicity in various psychiatric disorders.
    WORTIS J
    Am J Psychiatry; 1959 Oct; 116():309-11. PubMed ID: 13846006
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum aldolase activity in chronic heart failure].
    ORLOWSKI M
    Pol Tyg Lek (Wars); 1958 Jun; 13(22):851-3. PubMed ID: 13578757
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the dynamics of serum aldolase activity in patients of epidemic hepatitis].
    CAJAL N; TUDOR V; BABA C; LITMAN S; BOERU V
    Stud Cercet Inframicrobiol; 1957; 8(3):335-40. PubMed ID: 13529496
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum aldolase activity inacute heart disease.
    PETERSEN VP
    Acta Med Scand; 1959 Jun; 164(2):131-42. PubMed ID: 13669959
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of serum aldolase and transaminase activity in trichinosis; preliminary communication].
    MALIK A; NIEWIAROWSKI S; RACHON K
    Wiad Parazytol; 1958; 4(5-6):377-9; English transl 379-80. PubMed ID: 13604142
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum and cerebrospinal fluid uric acid levels in multiple sclerosis patients.
    Zamani A; Rezaei A; Khaeir F; Hooper DC
    Clin Neurol Neurosurg; 2008 Jun; 110(6):642-3. PubMed ID: 18471958
    [No Abstract]   [Full Text] [Related]  

  • 13. [A micro method for the determination of serum aldolase activity].
    ANAN'EV VA; OBUKHOVA VR
    Vopr Virusol; 1958; 3(2):119-20. PubMed ID: 13569986
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes of serum aldolase activity in the neonatal period in physiological, para-physiological and pathological conditions].
    MARTONI L; MUSIANI S
    Clin Pediatr (Bologna); 1958 May; 40(5):397-409. PubMed ID: 13573632
    [No Abstract]   [Full Text] [Related]  

  • 15. Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis.
    Mahovic D; Petravic D; Petelin Z; Zurak N; Horvat G; Hajnsek S
    Clin Neurol Neurosurg; 2004 Jun; 106(3):230-2. PubMed ID: 15177773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum aldolase content in experimental infarct in dogs].
    CHAZOV EI; SAVINA MM
    Biull Eksp Biol Med; 1958 Mar; 45(3):41-4. PubMed ID: 13535871
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum aldolase determination as a routine laboratory procedure.
    HARRIS ML
    Am J Med Technol; 1958; 24(2):99-105. PubMed ID: 13508667
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of serum aldolase in the clinical laboratory].
    KONITZER K; BINDING H
    Z Gesamte Inn Med; 1959 Mar; 14(5):252-5. PubMed ID: 13669548
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic significance of serum aldolase in liver diseases].
    SIMON M; KURTHY L; ELODI P; SOOS S; HORVATH B
    Orv Hetil; 1958 Aug; 99(35):1201-7. PubMed ID: 13600776
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biological determination of the toxicity of pathologic body fluids. I. Tests with body fluids of mental and neurological patients].
    RIEDER HP
    Confin Neurol; 1954; 14(2-3):65-87. PubMed ID: 13190852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.